This study aims to analyze the therapeutic effect of mecobalamin combined with edaravone in patients with diabetic peripheral neuropathy (DPN). A total of 65 patients with DPN treated in our hospital from May 2024 to May 2025 were randomly divided into a control group (32 cases, receiving conventional treatment plus mecobalamin) and an observation group (33 cases, receiving additional edaravone based on the control group regimen), and the treatment outcomes were compared between the two groups. The results showed that the observation group demonstrated significantly better nerve conduction velocity indices, serological markers, and vibration perception threshold (VPT) than the control group (P < 0.05). It is concluded that the combination of mecobalamin and edaravone can effectively improve nerve conduction velocity, serum indicators, and VPT in patients with DPN.

Dajing Jiang. Effect of Mecobalamin Combined with Edaravone on Nerve Conduction Velocity in Patients with Diabetic Peripheral Neuropathy. Frontiers in Medical Science Research (2026), Vol. 8, Issue 2: 44-48. https://doi.org/10.25236/FMSR.2026.080206.

[1] Yan Chunmei. Effect of lipoic acid + mecobalamin combined with epalrestat on vibration perception threshold in patients with diabetic peripheral neuropathy [J]. Chinese Journal of Coal Industry Medicine, 2022, 25 (1): 26-30.

[2] Shen Ming. Clinical efficacy of epalrestat combined with alpha-lipoic acid in the treatment of diabetic peripheral neuropathy and its effect on oxidative stress response [J]. Contemporary Medicine, 2022, 28 (26): 175-178.

[3] Li Hui, Huang Minglong, Lin Li. Effect of epalrestat combined with mecobalamin on peripheral neuropathy and plasma Hcy level in elderly patients with type 2 diabetes [J]. Journal of Clinical Research in Medicine, 2020,37 (9): 1399-1401.

[4] Wang Qi, Sun Xihua. Effect of intravenous thrombolytic therapy with edaravone and dextroborneol combined with urokinase on cerebral hemodynamics and neurological function in patients with acute cerebral infarction and diabetes [J]. Systems Medicine, 2023, 8 (23): 100-103.

[5] Zhao Dan. Study on the effect of Mudan granule combined with alpha-lipoic acid and mecobalamin on diabetic peripheral neuropathy and its influence on serum homocysteine and nerve conduction velocity [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2024, 26 (3): 189-193.

[6] Xia Li, Chen Kun, He Di. Effect of edaravone combined with alpha-lipoic acid on clinical signs and symptoms and nerve conduction function in patients with diabetic peripheral neuropathy [J]. Clinical Medical Engineering, 2024, 31 (3): 309-310.

[7] Sun Yongkang, Liu Jiantao, Zheng Shuran, et al. Effect of Fuyuan Xingnao Decoction combined with edaravone on vascular endothelial function and neurological deficit in patients with type 2 diabetes mellitus complicated with acute ischemic stroke [J]. Liaoning Journal of Traditional Chinese Medicine, 2020, 47 (12): 99-102.

[8] Wang Zhaochun. Analysis of therapeutic effect of edaravone injection combined with dapagliflozin on acute cerebral infarction patients with diabetes [J]. Diabetes New World, 2024, 27 (23): 104-106,117.

[9] Jiang Fei, Wang Dongyu. Effect of intravenous thrombolysis with edaravone dextroborneol combined with urokinase on serum oxidative stress level, common carotid artery intima-media thickness and serum matrix metalloproteinase-12 level in patients with acute cerebral infarction complicated with diabetes [J]. Shaanxi Medical Journal, 2022, 51 (1): 88-91.

[10] Wang Ying. Effect observation of edaravone combined with epalrestat on diabetic peripheral neuropathy [J]. China Higher Medical Education, 2021 (1): 139,141.